Genetic risk score for ovarian cancer based on chromosomal-scale length variation

by Brody, J.P, Toh, C.
Published 2021

Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse mod...

by Bridle, B.W, Lawler, J., Lo, K.-M, Matuszewska, K., Pereira, M., Petrik, D., Petrik, J., Santry, L.A, ten Kortenaar, S., Wootton, S.K
Published 2022

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association

by Anton-Culver, H., Berchuck, A., Chang-Claude, J., Cho, K., Cramer, D., Doherty, J.A, Fortner, R.T, Goodman, M.T, Hanley, G.E, Harris, H.R, Jensen, A., Jordan, S.J, Khoja, L., Kjaer, S.K, Lee, A.W, McLean, K., Modugno, F., Moysich, K., Mukherjee, B., Muthukumar, A., Pearce, C.L, Phung, M.T, Pike, M.C, Risch, H., Schildkraut, J.M, Terry, K.L, The Australian Ovarian Cancer Study Group, Webb, P.M, Weber, R.P, Wu, A.H, Ziogas, A.
Published 2022

New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improv...

by Abourehab, M.A.S, Afzal, S., Hasan, H., Hussain, Z., Safdar, M.H, Thu, H.E
Published 2018